Back to search

National and Kapodistrian University of Athens

Η κυτταροκίνη οστεοποντίνη στο υπερκείμενο των προκλητών πτυέλων και στον ορό αίματος ως βιολογικός δείκτης στην παθογένεια και τη βαρύτητα της νόσου στη χρόνια αποφρακτική πνευμονοπάθεια και στον καρκίνο πνεύμονα

Abstract

dc:description

Introduction: Osteopontin (OPN) has been involved in cancer development, angiogenesis and metastasis. Increased OPN sputum levels have been detected in COPD patients. Lung cancer (LC) and COPD may share common pathogenetic mechanisms; however, the role of OPN in the pathogenesis of both diseases has not been clarified yet. Objective: We attempted to determine whether the co-existence of LC and COPD affects serum OPN levels. Furthermore, to evaluate OPN prognostic performance in 1-year mortality in LC and its diagnostic performance in LC among COPD patients. Finally to assess OPN levels according to histological type and extent of disease. Methods: We recruited 167 patients with LC, 85 with concomitant COPD, whereas 28 patients with COPD served as control group. All subjects were followed for one year or until death. Results: OPN levels were significantly higher in patients with LC compared to those with COPD alone [median IQR ng/ml 40 (24-63) vs 32(19-36.5), p=0.017]. OPN levels were significantly higher in patients with COPD and LC compared to those with COPD alone [median IQR ng/ml [36 (23-59) vs 32 (19.0- 36.5), p=0.031]. No significant difference was observed between patients with LC and COPD vs those with LC without COPD [median IQR ng/ml 36 (23-59) vs 45 (24-69), p=0.171]. In multivariate Cox regression analysis, serum OPN ≥ 50.3 ng/ml was an independent predictor of 1-year mortality (HR 3.014 95% CI 1.821-5.130). OPN levels ≥35 ng/ml were able to predict the presence of concomitant LC in COPD patients, (AUC 0.636, 95%CI: 0.540- 0.725). Conclusion: In patients with LC and/or COPD, LC seems to be the major determinant for serum OPN levels. Serum OPN might be a promising prognostic biomarker for the survival of LC patients and possibly a diagnostic biomarker of LC among COPD patients.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2018

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Petta, Vasiliki
  • Πέττα, Βασιλική

Subjects

dc:subject × 16

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/43584

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Petta, Vasiliki; Πέττα, Βασιλική. Η κυτταροκίνη οστεοποντίνη στο υπερκείμενο των προκλητών πτυέλων και στον ορό αίματος ως βιολογικός δείκτης στην παθογένεια και τη βαρύτητα της νόσου στη χρόνια αποφρακτική πνευμονοπάθεια και στον καρκίνο πνεύμονα. National and Kapodistrian University of Athens, 2018. http://hdl.handle.net/10442/hedi/43584